artemether

Known as: 3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9- trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-, Methyl-dihydroartemisinine, (3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*))-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4.3-j)-1,2-benzodioxepin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2018
02040608019822018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Artemisinin combination therapies (ACTs) are currently the preferred option for treating uncomplicated malaria… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Uganda recently adopted artemether-lumefantrine (AL) as the recommended first-line treatment for uncomplicated malaria… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVES To compare the efficacy and safety of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) for… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Resistance of malaria parasites to chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) is increasing in prevalence in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Southeast Asia has the most resistant malaria parasites in the world, which severely limits treatment options. There… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Chemotherapy with praziquantel is the current strategy of choice to control schistosomiasis. However, in view of… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The new oral fixed combination artemether-lumefantrine (CGP 56697) has proved to be an effective and well-tolerated treatment of… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
AIMS To investigate the pharmacokinetic and pharmacodynamic properties of artemether and benflumetol in a fixed combination… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Several artemisinin (qinghaosu) derivatives have been developed and are in use as antimalarial drugs but scant animal or human… (More)
  • figure 2
Is this relevant?